FDA inspection
Guangzhou Haishi Biological Technology Co., Ltd.: FDA inspection ending Jul 24, 2015
FDA inspection 937019 · Official Action Indicated (OAI) · Guangzhou
Key facts
| Inspection ID | 937019 |
|---|---|
| Firm | Guangzhou Haishi Biological Technology Co., Ltd. |
| FEI number | 3010166847 |
| Address | 1/F,2/F, Bldg.1, no.3, Songyuan Rd, New Industrial Zone, No.11 She, Xiamao |
| City | Guangzhou |
| Country | China |
| Fiscal year | 2015 |
| Inspection end date | Jul 24, 2015 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 490848 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data